DCA Officials Seize ‘Diclojan Forte’ Tab For Misleading Claims

HYDERABAD: Officials of Drugs Control Administration, Telangana seized ‘DICLOJAN Forte Tablets (Diclofenac Sodium & Paracetamol Tablets),’ in Aiza Village, Jogulamba-Gadwal District, for making a misleading advertisement claiming it treats ‘fever.

In a statement here on Thursday, DCA Director-General VB Kamalasan Reddy said that the officials detected a medicine ‘DICLOJAN Forte Tablets’ circulating in the market with misleading claim on its label that it treats ‘fever’, which is a contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. During the special raids conducted on 24th, and 25th April, officials from the Drugs Control Administration, Mahabubnagar Zone, detected ‘DICLOJAN Forte Tablets’. The said medicine was detected by DCA officials at a medical shop situated in Aiza Village, Aiza Mandal, Jogulamba-Gadwal District. Stocks were seized during the raid.

The advertisement of a medicine for the treatment of ‘fever’ in general is prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Mohd. Rafhi Shaik, Drugs Inspector, Gadwal and A.N. Kranthi Kumar, Drugs Inspector, Narayanpet are among the officers who carried out the raid. Further investigation shall be carried out and action shall be taken as per the law against all the offenders.

Persons who make misleading advertisements regarding drugs for treatment of certain diseases and disorders are punishable under Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, with imprisonment which may extend to six months, or with fine, or with both.

The public may report any complaints regarding illegal activities concerning medicines through the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.

Related Posts

  • Pharma
  • May 25, 2024
  • 64 views
NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling price of asthma inhaler drug combination formoteral 6 mcg and budesonide 400 mcg dry power inhaler (DPI) under…

  • Pharma
  • May 25, 2024
  • 75 views
Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Jaipur: To provide quality education in pharmacy institutes, the central government has prepared to end the duplicate system. Strict action will be taken against fake students and teachers in newly opened…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

A Doctor diagnoses Mood of Voters in Delhi

A Doctor diagnoses Mood of Voters in Delhi

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

NPPA Revises Ceiling Price Of Asthma Inhaler Drug Combination In Suo-Moto Correction

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Students Will Not Be Able To Take Admission In Pharmacy Institutes With Fake Documents, Strict Monitoring

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Tripura Police Seized Banned Cough Syrup Worth Rs 30 Lakh In Dhalai; One Arrested

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Ex-Pharmacy Council Registrar Gave Certificates To Ineligible Candidates?

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research

Experts Call For Ethical Standards, Patient Advocacy In Clinical Research